Skip to main content

Alerts

View all our safety alerts, medicine shortage alerts and product recalls.

Use the filters below to narrow your search.

Filter results

You can narrow down the results using the filters.

16 result(s) found, displaying 1 to 16
  • Magnum XXL capsules pose a serious risk to your health and should not be taken.
  • More prominent warnings are being added to the Product Information and Consumer Medicine Information for all oral and injectable (systemic) fluoroquinolones to strengthen existing warnings about serious side effects.
  • Extra safety information is being added to all montelukast products to highlight the existing warnings about serious behaviour and mood-related changes
  • Robust Extreme capsules pose a serious risk to your health and should not be taken.
  • There have been reports of the dose counter stopping after the 10th dose and not locking after the 60th dose. If this happens, you should return the product to your place of purchase or contact Boehringer Ingelheim.
  • There are new warnings about the risks of heart attack and stroke with taking romosozumab (Evenity). The Product Information (PI) and Consumer Medicine Information (CMI) have been updated to reflect these risks.
  • Our safety advisory includes information for consumers and health professionals about low levels of nitrosamine impurity in medicines containing sitagliptin.
  • Find out how we are investigating low levels of the nitrosamine impurity in medicines containing fluoxetine. Read information for consumers and health professionals.
  • Safety advisory - low levels of contamination with a nitrosamine impurity
  • TGA investigation - potential low levels of contamination with N-nitrosovarenicline
  • Update 2 - contamination with N-nitrosodimethylamine

Help us improve this page